The Serum Institute of India’s £50 Million Investment in Oxford Biomedica

Covington & Burling advised Oxford Biomedica on the deal.The Serum Institute of India, the world’s largest vaccine maker, has agreed, via its subsidiary Serum Life Sciences…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now